Yanping Mao

20PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 01, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

|Jun 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial.

|May 14, 2026
MYO1G Facilitates Caveolin 1-Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy.

|Mar 31, 2026
Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial.

Shun-Xin Wang, Ya-Lan Tao, Tian-Sheng Gao

|Mar 12, 2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.

Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang

|Feb 25, 2026
PD-1 inhibitors combined with induction chemotherapy followed by chemoradiotherapy in HPV-negative locally advanced head and neck squamous cell carcinoma: a real-world study.

Yi Yang, Shunxin Wang, Shuzhen Peng

Pageof 4

Frequent Collaborators

11 joint publications

Jun Ma

9 joint publications

Ying Sun

7 joint publications

Ling-Long Tang

5 joint publications

Na Liu